State Street’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.11M | Sell |
614,293
-12,848
| -2% | -$44.1K | ﹤0.01% | 3299 |
|
|
2025
Q1 | $1.4M | Buy |
627,141
+302,339
| +93% | +$674K | ﹤0.01% | 3358 |
|
|
2024
Q4 | $952K | Buy |
324,802
+1,573
| +0.5% | +$4.61K | ﹤0.01% | 3497 |
|
|
2024
Q3 | $840K | Buy |
323,229
+4,679
| +1% | +$12.2K | ﹤0.01% | 3515 |
|
|
2024
Q2 | $943K | Sell |
318,550
-131,705
| -29% | -$390K | ﹤0.01% | 3481 |
|
|
2024
Q1 | $2.04M | Sell |
450,255
-10,645
| -2% | -$48.2K | ﹤0.01% | 3273 |
|
|
2023
Q4 | $2.63M | Buy |
460,900
+44,722
| +11% | +$255K | ﹤0.01% | 3224 |
|
|
2023
Q3 | $1.91M | Buy |
416,178
+163,738
| +65% | +$753K | ﹤0.01% | 3355 |
|
|
2023
Q2 | $1.63M | Sell |
252,440
-3,137,365
| -93% | -$20.3M | ﹤0.01% | 3473 |
|
|
2023
Q1 | $25.6M | Buy |
3,389,805
+120,418
| +4% | +$908K | ﹤0.01% | 2057 |
|
|
2022
Q4 | $33.1M | Buy |
3,269,387
+58,568
| +2% | +$593K | ﹤0.01% | 1910 |
|
|
2022
Q3 | $31.8M | Buy |
3,210,819
+16,510
| +0.5% | +$163K | ﹤0.01% | 1906 |
|
|
2022
Q2 | $34M | Buy |
3,194,309
+2,925,279
| +1,087% | +$31.2M | ﹤0.01% | 1882 |
|
|
2022
Q1 | $2.62M | Buy |
269,030
+89,823
| +50% | +$876K | ﹤0.01% | 3468 |
|
|
2021
Q4 | $2.56M | Buy |
179,207
+52,739
| +42% | +$754K | ﹤0.01% | 3565 |
|
|
2021
Q3 | $2.53M | Buy |
+126,468
| New | +$2.53M | ﹤0.01% | 3548 |
|